Un aspecto importante es que el GLP-1 endgeno tiene una vida media muy corta (aproximadamente 1-2 minutos) porque es rpidamente degradado por la enzima dipeptidil peptidasa-4 (DPP-4), lo que limita sus efectos fisiolgicos naturales
"There is no head-to-head trial comparing the efficacy of orforglipron and Wegovy pill and Wegovy pill has demonstrated a magnitude of weight loss no other oral GLP-1 obesity candidate by itself, as a singular molecule, has shown in a Phase III study without the benefit of another agent." Lilly has submitted orforglipron for weight management and/or type 2 diabetes in more than 40 countries and plans to launch in each country shortly after approval.
Both the injections and pills have similar side effects, including nausea, constipation, vomiting, gallbladder disease, and other gastrointestinal issues
Common contributors include sleep disorders, nutritional deficiencies (particularly vitamin B12 and iron), hormonal imbalances, chronic stress, anxiety, depression, and various medical conditions such as hypothyroidism
In February, Novo Nordisk said more than 170,000 people were taking the Wegovy pill after it launched in January
Finally, the checkout process is built on auto-subscribes, shifting discounts, and aggressive pop-ups designed to lock you in